Vaxcyte, Inc.

NasdaqGS:PCVX Rapporto sulle azioni

Cap. di mercato: US$10.7b

Vaxcyte Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Grant Pickering

Amministratore delegato

US$12.1m

Compenso totale

Percentuale dello stipendio del CEO5.3%
Mandato del CEO11yrs
Proprietà del CEO0.5%
Durata media del management4.5yrs
Durata media del Consiglio di amministrazione5.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy

Sep 06

We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Aug 24
We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

May 10
Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Dec 27
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Sep 12
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

May 30
Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Dec 22
We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Vaxcyte appoints new CBO, CMO

Oct 11

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Aug 05
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Vaxcyte completes enrollment in phase 2 portion of study of pneumonia vaccine candidate

Jul 12

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Grant Pickering rispetto agli utili di Vaxcyte?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$508m

Jun 30 2024n/an/a

-US$497m

Mar 31 2024n/an/a

-US$437m

Dec 31 2023US$12mUS$640k

-US$402m

Sep 30 2023n/an/a

-US$300m

Jun 30 2023n/an/a

-US$265m

Mar 31 2023n/an/a

-US$245m

Dec 31 2022US$14mUS$601k

-US$223m

Sep 30 2022n/an/a

-US$174m

Jun 30 2022n/an/a

-US$143m

Mar 31 2022n/an/a

-US$118m

Dec 31 2021US$5mUS$575k

-US$100m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$87m

Mar 31 2021n/an/a

-US$83m

Dec 31 2020US$3mUS$481k

-US$89m

Sep 30 2020n/an/a

-US$83m

Jun 30 2020n/an/a

-US$73m

Mar 31 2020n/an/a

-US$64m

Dec 31 2019US$596kUS$426k

-US$50m

Compensazione vs Mercato: La retribuzione totale di Grant ($USD 12.14M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 12.73M ).

Compensazione vs guadagni: La retribuzione di Grant è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Grant Pickering (56 yo)

11yrs

Mandato

US$12,135,683

Compensazione

Mr. Grant E. Pickering, M.B.A., is Co-Founder of Vaxcyte, Inc. since 2013 and has been its Chief Executive Officer and Director since November 2013 and served as its President since November 2013 until Dec...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Grant Pickering
Co-Founder11yrsUS$12.14m0.53%
$ 56.9m
Andrew Guggenhime
President & CFO4.5yrsUS$5.42m0.059%
$ 6.4m
James Wassil
Executive VP & COO4.9yrsUS$5.40m0.14%
$ 14.9m
Mikhail Eydelman
Senior VP2.6yrsUS$3.49m0.0081%
$ 870.0k
Ashish Khanna
Co-Founder11.8yrsNessun datoNessun dato
Jeff Fairman
Co-Founder & VP of Researchno dataNessun datoNessun dato
Elvia Cowan
Senior VP of Finance & Principal Accounting Officer1.8yrsNessun dato0.0031%
$ 335.3k
Janet Graesser
Senior Vice President of Corporate Communications & Investor Relationsno dataNessun datoNessun dato
Whitney Jones
Chief People Officerless than a yearNessun datoNessun dato
Paul Sauer
Senior Vice President of Process Development & Manufacturing8.6yrsUS$2.35mNessun dato
Harp Dhaliwal
Senior Vice President of Commercial Manufacturing & Supply Chain3yrsUS$1.84mNessun dato
Sam Iki
Senior Vice President of Project Managementno dataNessun datoNessun dato

4.5yrs

Durata media

55yo

Età media

Gestione esperta: Il team dirigenziale di PCVX è considerato esperto (durata media dell'incarico 4.5 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Grant Pickering
Co-Founder11yrsUS$12.14m0.53%
$ 56.9m
Annie Drapeau
Independent Director3.2yrsUS$704.22k0.0045%
$ 483.2k
K. Hirth
Independent Director8.2yrsUS$696.72k0.010%
$ 1.1m
Heath Lukatch
Independent Director6.5yrsUS$691.72k0.0045%
$ 483.2k
Halley Gilbert
Independent Director4.6yrsUS$704.22k0.0045%
$ 483.2k
Emmanuel Walter
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Carlos Paya
Independent Chairman of the Board3.1yrsUS$724.22k0.0045%
$ 483.2k
Anthony Ford-Hutchinson
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Jeffrey Almond
Member of Scientific Advisory Board7.8yrsNessun datoNessun dato
Teri Loxam
Independent Director3.2yrsUS$704.22k0.0045%
$ 483.2k
Emmanuel Hanon
Member of Scientific Advisory Boardno dataNessun datoNessun dato
William Hausdorff
Member of Scientific Advisory Boardno dataNessun datoNessun dato

5.5yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PCVX sono considerati esperti (durata media dell'incarico 5.5 anni).